Timothy P. Noyes, CHIEF EXECUTIVE OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 17,353 shares at $31.02 ($519K) on 2024-04-01, disclosed to the SEC on 2024-04-03.
Scheduled sale ($519k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.96 | 4,502 | $130K | 25.1% |
| 2 | $28.96 | 4,502 | $130K | 25.1% |
| 3 | $29.90 | 1,647 | $49K | 9.5% |
| 4 | $31.02 | 2,851 | $88K | 17.0% |
| 5 | $31.02 | 2,851 | $88K | 17.0% |
| 6 | $31.95 | 1,000 |
| $32K |
| 6.2% |
| Total | $29.90 avg | 17,353 | $519K | 100% |
| Filing → |
| AVTE | SELL | 2024-04-18 | $494K | — | Filing → |
| AVTE | SELL | 2023-11-03 | $11K | — | Filing → |
| AVTE | SELL | 2023-08-01 | $99K | — | Filing → |